Skip to content

The effect of pharmaceutical care intervention on health care and the safety of medication use in hospitalized elderly

The impact of pharmaceutical care in the context of individualized-centered health care for the safety of pharmacotherapy in hospitalized elderly: a clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-34f2px4
Enrollment
Unknown
Registered
2021-05-14
Start date
2021-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-Related Side Effects and Adverse Reactions

Interventions

Intervention: Number of participants = 160. After inclusion, the participants will be accompanied, by pharmaceutical care (PC), during the time they are hospitalized in the geriatric ward, from July t
collection of subjective and objective data
evaluation
care plan and resolution indicators). The registration of information will be based on SOAP (collection of Subjective and Objectives data for later Assessment and organization of the conduct Plan) whi

Sponsors

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP)
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Being 60 years old or more; being on one or more prescription drugs; have a source of confirmation of the drugs you routinely use, such as medical records or history of care in primary health care, or be aware to report this information, or even have a companion who holds this data about your treatment; to be admitted to the geriatric ward for at least 24 hours and, after this time has elapsed, not to be discharged from the hospital already scheduled; consent to participate in the study and sign, or the responsible person, the informed consent form

Exclusion criteria

Exclusion criteria: Withdraw the consent to participate in the course of the research, due to the individual's will or the person responsible for it

Design outcomes

Primary

MeasureTime frame
Frequency of adverse drug events and medication errors identified during the study period, verified through the intervention of pharmaceutical care in geriatrics.;Frequency of participants who died during 30, 60 and 90 days of hospitalization, verified by means of death confirmation attested by the documentation present in the hospital record.;Average time in days that the participants stayed in the hospital, verified by means of the total of this period verified in the hospital record.;Frequency of participants who were admitted to new hospitalizations after 30, 60 and 90 days after discharge from hospital initially assessed, verified through the flow of admissions in the unit during the research period and also by the participants' hospital records.;Frequency of participants who died during 30, 60 and 90 days after hospital discharge, verified by means of death confirmation attested by the documentation present in the hospital record and, for some cases and if necessary, contact with the participants will be made by telephone after 30, 60 and 90 days of discharge, to determine whether they died during that period.

Secondary

MeasureTime frame
Accounting for the frequency of the total number of medications in use by the individual at the beginning and at the end of hospitalization, verified through the prescription of medications at admission and at hospital discharge.;Frequency of drugs that are related to adverse drug events and medication errors identified in geriatrics, verified through the intervention of pharmaceutical care. The drugs will be named according to the brazilian common denomination.;Rate of acceptance of the conducts proposed by the intervention of the pharmaceutical care, verified through the approval of the recommendation described in the care plan of the patient's medical record. If the recommendation suggests a modification, it will be assessed whether it has been implemented so that it can be considered approved.;Satisfaction of the geriatric ward health team in relation to the collaboration of pharmaceutical care in the assistance, verified by means of an instrument that assesses the perception of professionals regarding the importance of pharmaceutical care in the ward. The instrument will be made available via e-mail and, for professionals who choose, the printed version will be provided. On the last day of the intervention, the survey will be sent and after the consent form has been given, the professionals will have 15 days to return their answers. Through the frequency of the response of each item, the satisfaction of the team will be determined.

Countries

Brazil

Contacts

Public ContactAlan de Oliveira
alanoliveira@usp.br+55-16-33154181

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 12, 2026